The evaluation system by the group around Ruschoff, which was applied in the present work, takes into account the tumor specific characteristics of Her2 staining in gastric cancer as opposed to breast carcinoma, and represents a first step towards standardization of Her2 assessment in this tumor entity [20,23]. Here, ERBB2 is linked to breast carcinoma.